(Total Views: 677)
Posted On: 05/02/2022 9:36:39 PM
Post# of 153886

Re: Evil Rabbit #122792
"We expect there to be significant interest from industry stakeholders...
in the development of Leronlimab for the treatment of NASH". Brendan Rae...
Why is he not presenting instead of Scott Kelly.?...he's every bit as strong as Scott on the delivery front.
in the development of Leronlimab for the treatment of NASH". Brendan Rae...
Why is he not presenting instead of Scott Kelly.?...he's every bit as strong as Scott on the delivery front.

